Research Article
Increased Body Mass Index during Therapy for Childhood Acute Lymphoblastic Leukemia: A Significant and Underestimated Complication
Table 2
Mean BMI
-scores at the end of treatment for ALL.
|
Age at diagnosis | Males | Females | ALL mean BMI -score (95% CI) | Healthy mean BMI -score | Difference in mean BMI -score (ALL-healthy) | ALL mean BMI -score (95% CI) | Healthy mean BMI -score | Difference in mean BMI -score (ALL-healthy) |
| Standard risk | | | | | | | 2 | 1.04 (0.77, 1.32) | 0.17 | 0.88 | 1.23 (0.86, 1.61) | 0.10 | 1.13 | 4 | 0.82 (0.58, 1.06) | 0.21 | 0.61 | 1.25 (0.95, 1.55) | 0.15 | 1.10 | 6 | 0.59 (0.35, 0.84) | 0.29 | 0.31 | 1.27 (0.93, 1.61) | 0.24 | 1.03 | 8 | 0.37 (0.06, 0.68) | 0.35 | 0.02 | 1.29 (0.83, 1.75) | 0.32 | 0.97 | 10 | 0.14 (−0.25, 0.54) | 0.37 | −0.22 | 1.31 (0.68, 1.93) | 0.38 | 0.93 | High risk | | | | | | | 10 | 0.30 (−0.07, 0.67) | 0.37 | −0.06 | 0.45 (−0.03, 0.92) | 0.38 | 0.07 | 12 | 0.08 (−0.30, 0.45) | 0.34 | −0.26 | 0.47 (0.002, 0.93) | 0.40 | 0.07 |
|
|